Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 1250.00 | 859.67 | 1634.00 | 2002.25 | 0.8161 | 0.6930 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 1882.00 | 2002.25 | 0.9399 | 0.9010 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 1250.00 | 859.67 | 2096.00 | 2002.25 | 1.0468 | 1.0765 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1334.00 | 2002.25 | 0.6663 | 0.4337 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 1250.00 | 859.67 | 1845.00 | 2002.25 | 0.9215 | 0.8703 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2023.00 | 2002.25 | 1.0104 | 1.0170 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1.00 | 2002.25 | 0.0005 | -0.9961 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 3.00 | 2002.25 | 0.0015 | -0.9903 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1930.00 | 2002.25 | 0.9639 | 0.9406 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1597.00 | 2002.25 | 0.7976 | 0.6616 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1648.00 | 2002.25 | 0.8231 | 0.7049 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 966.00 | 2002.25 | 0.4825 | 0.1003 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 1250.00 | 859.67 | 1807.00 | 2002.25 | 0.9025 | 0.8387 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 1250.00 | 859.67 | 846.00 | 2002.25 | 0.4225 | -0.0131 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 2095.00 | 2002.25 | 1.0463 | 1.0756 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 1250.00 | 859.67 | 904.00 | 2002.25 | 0.4515 | 0.0421 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1989.00 | 2002.25 | 0.9934 | 0.9891 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 1250.00 | 859.67 | 1185.00 | 2002.25 | 0.5918 | 0.3010 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 1250.00 | 859.67 | 1168.00 | 2002.25 | 0.5833 | 0.2857 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2155.00 | 2002.25 | 1.0763 | 1.1243 | |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 1250.00 | 859.67 | 1044.00 | 2002.25 | 0.5214 | 0.1727 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1867.00 | 2002.25 | 0.9325 | 0.8886 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 1250.00 | 859.67 | 1024.00 | 2002.25 | 0.5114 | 0.1542 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 1250.00 | 859.67 | 1239.00 | 2002.25 | 0.6188 | 0.3494 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 1250.00 | 859.67 | 1880.00 | 2002.25 | 0.9389 | 0.8993 |